Axsome Therapeutics to Acquire Sunosi from Jazz Pharmaceuticals

The acquisition of Sunosi adds a high-potential commercial asset to Axsome’s late-stage neuroscience portfolio.

Related Keywords

China ,Japan ,United States ,Herriot Tabuteau ,Bruce Cozadd ,Symphony Health Data ,Axsome Therapeutics Inc ,European Medicines Agency ,Jazz Pharmaceuticals ,Drug Administration ,Hercules Capital Inc ,Digital Centric Commercialization ,High Potential Commercial Asset ,Late Stage Neuroscience ,Therapeutic Focus ,Deliver Substantial Shareholder ,Aerial Biopharma ,Hercules Capital ,Hart Scott Rodino Antitrust Improvements Act ,